Clinical trials in cancer therapy

Efforts to improve patient enrollment by community oncologists

W. B. Fisher, S. J. Cohen, M. K. Hammond, S. Turner, Patrick Loehrer

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

A prerequisite for the completion of a clinical trial is the accrual of adequate numbers of patients. It is estimated that over 90-95% of all cancer patients are now treated in their local communities by practicing oncologists and are not seen by primary investigators at teaching hospitals. One risk of this trend is decreased patient enrollment into clinical trials. The private practitioner often lacks the academic oncologist's incentives to participate in clinical research. The Hoosier Oncology Group (HOG) is composed of community medical and radiation oncologists (85%) and Indiana University faculty members (15%). In an effort to improve patient enrollment onto clinical cancer research trials, HOG has attempted to identify 1) the major obstacles to patient enrollment by community oncologists and 2) potential aids to overcome such obstacles. One hundred fourteen members were surveyed and 75 responded (66%). The major obstacles were, in descending order: time demands on both the oncologist and his staff; explaining clinical trials to patients; completing flow sheets; perceived increased cost to the patient; remembering protocols; adhering to a rigid protocol. Aids identified as potentially most helpful were, in descending order: pocket-sized synopses of protocols; computer generated, individualized prompts; the availability of a clinical trials specialist to explain the clinical trial to patients and assist in obtaining informed consent; the availability of a video tape which could be used to explain clinical trials to patients. These aids are being implemented with the attempt to systemically study their impact on patient accrual.

Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalMedical and Pediatric Oncology
Volume19
Issue number3
StatePublished - 1991

Fingerprint

Clinical Trials
Neoplasms
Therapeutics
Oncologists
Informed Consent
Research
Teaching Hospitals
Motivation
Research Personnel
Costs and Cost Analysis

Keywords

  • Cancer patients
  • Local communities
  • Practicing oncologists

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical trials in cancer therapy : Efforts to improve patient enrollment by community oncologists. / Fisher, W. B.; Cohen, S. J.; Hammond, M. K.; Turner, S.; Loehrer, Patrick.

In: Medical and Pediatric Oncology, Vol. 19, No. 3, 1991, p. 165-168.

Research output: Contribution to journalArticle

Fisher, W. B. ; Cohen, S. J. ; Hammond, M. K. ; Turner, S. ; Loehrer, Patrick. / Clinical trials in cancer therapy : Efforts to improve patient enrollment by community oncologists. In: Medical and Pediatric Oncology. 1991 ; Vol. 19, No. 3. pp. 165-168.
@article{d7645f990de240a89424a316d3408c21,
title = "Clinical trials in cancer therapy: Efforts to improve patient enrollment by community oncologists",
abstract = "A prerequisite for the completion of a clinical trial is the accrual of adequate numbers of patients. It is estimated that over 90-95{\%} of all cancer patients are now treated in their local communities by practicing oncologists and are not seen by primary investigators at teaching hospitals. One risk of this trend is decreased patient enrollment into clinical trials. The private practitioner often lacks the academic oncologist's incentives to participate in clinical research. The Hoosier Oncology Group (HOG) is composed of community medical and radiation oncologists (85{\%}) and Indiana University faculty members (15{\%}). In an effort to improve patient enrollment onto clinical cancer research trials, HOG has attempted to identify 1) the major obstacles to patient enrollment by community oncologists and 2) potential aids to overcome such obstacles. One hundred fourteen members were surveyed and 75 responded (66{\%}). The major obstacles were, in descending order: time demands on both the oncologist and his staff; explaining clinical trials to patients; completing flow sheets; perceived increased cost to the patient; remembering protocols; adhering to a rigid protocol. Aids identified as potentially most helpful were, in descending order: pocket-sized synopses of protocols; computer generated, individualized prompts; the availability of a clinical trials specialist to explain the clinical trial to patients and assist in obtaining informed consent; the availability of a video tape which could be used to explain clinical trials to patients. These aids are being implemented with the attempt to systemically study their impact on patient accrual.",
keywords = "Cancer patients, Local communities, Practicing oncologists",
author = "Fisher, {W. B.} and Cohen, {S. J.} and Hammond, {M. K.} and S. Turner and Patrick Loehrer",
year = "1991",
language = "English",
volume = "19",
pages = "165--168",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Clinical trials in cancer therapy

T2 - Efforts to improve patient enrollment by community oncologists

AU - Fisher, W. B.

AU - Cohen, S. J.

AU - Hammond, M. K.

AU - Turner, S.

AU - Loehrer, Patrick

PY - 1991

Y1 - 1991

N2 - A prerequisite for the completion of a clinical trial is the accrual of adequate numbers of patients. It is estimated that over 90-95% of all cancer patients are now treated in their local communities by practicing oncologists and are not seen by primary investigators at teaching hospitals. One risk of this trend is decreased patient enrollment into clinical trials. The private practitioner often lacks the academic oncologist's incentives to participate in clinical research. The Hoosier Oncology Group (HOG) is composed of community medical and radiation oncologists (85%) and Indiana University faculty members (15%). In an effort to improve patient enrollment onto clinical cancer research trials, HOG has attempted to identify 1) the major obstacles to patient enrollment by community oncologists and 2) potential aids to overcome such obstacles. One hundred fourteen members were surveyed and 75 responded (66%). The major obstacles were, in descending order: time demands on both the oncologist and his staff; explaining clinical trials to patients; completing flow sheets; perceived increased cost to the patient; remembering protocols; adhering to a rigid protocol. Aids identified as potentially most helpful were, in descending order: pocket-sized synopses of protocols; computer generated, individualized prompts; the availability of a clinical trials specialist to explain the clinical trial to patients and assist in obtaining informed consent; the availability of a video tape which could be used to explain clinical trials to patients. These aids are being implemented with the attempt to systemically study their impact on patient accrual.

AB - A prerequisite for the completion of a clinical trial is the accrual of adequate numbers of patients. It is estimated that over 90-95% of all cancer patients are now treated in their local communities by practicing oncologists and are not seen by primary investigators at teaching hospitals. One risk of this trend is decreased patient enrollment into clinical trials. The private practitioner often lacks the academic oncologist's incentives to participate in clinical research. The Hoosier Oncology Group (HOG) is composed of community medical and radiation oncologists (85%) and Indiana University faculty members (15%). In an effort to improve patient enrollment onto clinical cancer research trials, HOG has attempted to identify 1) the major obstacles to patient enrollment by community oncologists and 2) potential aids to overcome such obstacles. One hundred fourteen members were surveyed and 75 responded (66%). The major obstacles were, in descending order: time demands on both the oncologist and his staff; explaining clinical trials to patients; completing flow sheets; perceived increased cost to the patient; remembering protocols; adhering to a rigid protocol. Aids identified as potentially most helpful were, in descending order: pocket-sized synopses of protocols; computer generated, individualized prompts; the availability of a clinical trials specialist to explain the clinical trial to patients and assist in obtaining informed consent; the availability of a video tape which could be used to explain clinical trials to patients. These aids are being implemented with the attempt to systemically study their impact on patient accrual.

KW - Cancer patients

KW - Local communities

KW - Practicing oncologists

UR - http://www.scopus.com/inward/record.url?scp=0025906419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025906419&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 165

EP - 168

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -